99 related articles for article (PubMed ID: 8497845)
1. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
[TBL] [Abstract][Full Text] [Related]
2. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues.
Grignani G; Pacchiarini L; Ricetti MM; Dionigi P; Jemos V; Zucchella M; Fratino P
Invasion Metastasis; 1989; 9(5):298-309. PubMed ID: 2767927
[TBL] [Abstract][Full Text] [Related]
4. Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of "in vitro" culture.
Pacchiarini L; Meloni F; Zucchella M; Mangiarotti P; Tacconi F; Ballabio P; Grignani G
Haematologica; 1991; 76(5):392-7. PubMed ID: 1806443
[TBL] [Abstract][Full Text] [Related]
5. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
[TBL] [Abstract][Full Text] [Related]
6. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human tumor cells with human platelets and the coagulation system.
Al-Mondhiry H; McGarvey V; Leitzel K
Thromb Haemost; 1983 Oct; 50(3):726-30. PubMed ID: 6648893
[TBL] [Abstract][Full Text] [Related]
8. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
Kaplinska K; Mielicki WP
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):315-20. PubMed ID: 19448531
[TBL] [Abstract][Full Text] [Related]
9. Hemostasis and cancer: tumor cells induce the expression of tissue factor-like procoagulant activity on endothelial cells.
Maiolo A; Tua A; Grignani G
Haematologica; 2002 Jun; 87(6):624-8. PubMed ID: 12031919
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation.
Amirkhosravi M; Francis JL
Thromb Haemost; 1995 Jan; 73(1):59-65. PubMed ID: 7740497
[TBL] [Abstract][Full Text] [Related]
11. High expression of glycosphingolipids involved in procoagulant activity of cancer cells.
Suzuki M; Ando O; Ohta T; Inufusa H; Adachi T; Yasutomi M; Kurimoto M
Oncol Rep; 1999; 6(1):113-5. PubMed ID: 9864412
[TBL] [Abstract][Full Text] [Related]
12. [Cancer procoagulant (CP)].
Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
[TBL] [Abstract][Full Text] [Related]
13. A factor X-activating cysteine protease from malignant tissue.
Gordon SG; Cross BA
J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
[TBL] [Abstract][Full Text] [Related]
14. Factor X-activating activity from Guerin epithelioma.
Mielicki W; Wierzbicki R
Neoplasma; 1988; 35(3):279-84. PubMed ID: 3405336
[TBL] [Abstract][Full Text] [Related]
15. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.
Ricca A; Biroccio A; Trisciuoglio D; Cippitelli M; Zupi G; Del Bufalo D
Br J Cancer; 2001 Dec; 85(12):1914-21. PubMed ID: 11747334
[TBL] [Abstract][Full Text] [Related]
16. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor expression in human leukocytes and tumor cells.
Rickles FR; Hair GA; Zeff RA; Lee E; Bona RD
Thromb Haemost; 1995 Jul; 74(1):391-5. PubMed ID: 8578492
[TBL] [Abstract][Full Text] [Related]
18. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
[TBL] [Abstract][Full Text] [Related]
20. Cancer procoagulant in acute lymphoblastic leukemia.
Alessio MG; Falanga A; Consonni R; Bassan R; Minetti B; Donati MB; Barbui T
Eur J Haematol; 1990 Aug; 45(2):78-81. PubMed ID: 2209822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
